Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.290
+0.060 (2.69%)
May 7, 2026, 4:00 PM EDT - Market closed
CELZ Market Cap
CELZ has a market cap or net worth of $8.47 million as of May 8, 2026. Its market cap has increased by 148.98% in one year.
Market Cap
8.47M
Enterprise Value
1.27M
1-Year Change
148.98%
Ranking
Category
Stock Price
$2.29
Market Cap Chart
Since December 3, 2021, CELZ's market cap has decreased from $16.10M to $8.47M, a decrease of -47.42%. That is a compound annual growth rate of -13.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 7, 2026 | 8.50M | 66.67% |
| Dec 31, 2025 | 5.10M | 27.50% |
| Dec 31, 2024 | 4.00M | -37.50% |
| Dec 29, 2023 | 6.40M | 18.52% |
| Dec 30, 2022 | 5.40M | -66.46% |
| Dec 31, 2021 | 16.10M | - |
| Dec 3, 2021 | 16.10M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 9.20M |
| NuCana | 9.20M |
| Bolt Biotherapeutics | 8.95M |
| XTL Biopharmaceuticals | 8.47M |
| Evogene | 8.36M |
| PharmaCyte Biotech | 8.27M |
| Genprex | 8.20M |
| Can-Fite BioPharma | 7.77M |